MedTrace Logo

FLIO and the Influence of Oral Lutein Supplementation on Macular Pigment

NCT04761341 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2023-01-26

No results posted yet for this study

Summary

To investigate the effects of lutein supplementation on macular pigment density using FLIO and MPOD measurements in patients with age-related macular degeneration and healthy subjects over a course of 6 months.

Conditions

  • Age Related Macular Degeneration

Interventions

DRUG

NUTROF TOTAL

1 per day over a course of 3 months

Sponsors & Collaborators

  • Insel Gruppe AG, University Hospital Bern

    lead OTHER

Principal Investigators

  • Martin Zinkernagel, MD, PHD · Department of Ophthalmology, Inselspital, Bern University Hostpital, University of Bern, Bern, Switzerland

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-01
Primary Completion
2019-10-22
Completion
2019-10-22

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04761341 on ClinicalTrials.gov